Plus Therapeutics (PSTV) Institutional Ownership $1.09 +0.10 (+10.10%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Plus Therapeutics (NASDAQ:PSTV)CurrentInstitutional OwnershipPercentage3.28%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$835.96KNumber ofInstitutional Sellers(last 12 months)0 Get PSTV Insider Trade Alerts Want to know when executives and insiders are buying or selling Plus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PSTV Institutional Buying and Selling by Quarter Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> Plus Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/7/2024 AIGH Capital Management LLC568,681$836K0.3%N/A9.977% 11/15/2022 Parkman Healthcare Partners LLC1,325,025$590K0.2%-13.6%3.943% 8/8/2022 Otter Creek Advisors LLC330,168$178K0.1%+293.5%1.465% 5/13/2022 Parkman Healthcare Partners LLC1,526,316$1.53M0.4%N/A6.875% 5/9/2022 Otter Creek Advisors LLC83,901$84K0.0%N/A0.378% 11/9/2021BlackRock Inc.128,323$245K0.0%-19.7%0.835% 9/17/2021 Virtu Financial LLC76,187$195K0.0%N/A0.630% 8/16/2021 State Street Corp34,214$88K0.0%N/A0.283% 8/13/2021 Renaissance Technologies LLC17,607$45K0.0%N/A0.146% 8/13/2021 Northern Trust Corp40,524$104K0.0%N/A0.335% 8/13/2021 Geode Capital Management LLC130,793$334K0.0%N/A1.082% 8/13/2021 Vanguard Group Inc.712,847$1.83M0.0%+824.7%5.897% 8/12/2021 Dimensional Fund Advisors LP68,430$175K0.0%N/A0.566% 8/11/2021Susquehanna Fundamental Investments LLC13,033$33K0.0%N/A0.108% 2/24/2021 Virtu Financial LLC18,318$37K0.0%-16.5%0.383% 2/10/2021 Renaissance Technologies LLC106,100$214K0.0%+202.7%2.220% 1/29/2021 Creative Planning13,856$28K0.0%N/A0.290% 12/11/2020 Virtu Financial LLC21,932$56K0.0%N/A0.459% (Data available from 1/1/2016 forward) PSTV Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PSTV shares? During the previous two years, the following institutional investors and hedge funds held shares of Plus Therapeutics shares: AIGH Capital Management LLC ($836K).Learn more on PSTV's institutional investors. What percentage of Plus Therapeutics stock is owned by institutional investors? 3.28% of Plus Therapeutics stock is owned by institutional investors. Learn more on PSTV's institutional investor holdings. Which institutional investors have been buying Plus Therapeutics stock? The following institutional investors have purchased Plus Therapeutics stock in the last 24 months: AIGH Capital Management LLC ($568.68K). How much institutional buying is happening at Plus Therapeutics? Institutional investors have bought a total of 568,681 shares in the last 24 months. This purchase volume represents approximately $835.96K in transactions. Related Companies Femasys Institutional Ownership Co-Diagnostics Institutional Ownership DarioHealth Institutional Ownership Vivos Therapeutics Institutional Ownership Allurion Technologies Institutional Ownership NeurAxis Institutional Ownership Microbot Medical Institutional Ownership Nephros Institutional Ownership ReWalk Robotics Institutional Ownership Inspira Technologies Oxy B.H.N. Institutional Ownership This page (NASDAQ:PSTV) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Plus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Plus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
